Medpace
MEDP
357 hedge funds and large institutions have $4.07B invested in Medpace in 2022 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 118 increasing their positions, 147 reducing their positions, and 27 closing their positions.
74% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 27
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
19% more call options, than puts
Call options by funds: $21.9M | Put options by funds: $18.4M
5.45% more ownership
Funds ownership: 78.04% → 83.49% (+5.4%)
5% more funds holding
Funds holding: 340 → 357 (+17)
3% more capital invested
Capital invested by funds: $3.94B → $4.07B (+$129M)
20% less repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 147
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$53.2M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$43.7M |
| 3 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$23M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$18.3M |
| 5 |
Man Group
London,
United Kingdom
|
+$15.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$61.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$35.8M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$35.1M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$34.7M |
| 5 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$17.3M |
MEDP Hedge Fund Activity: Q3 2022 in Review
357 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q3 2022, worth a combined $4.07B — up 3.3% from $3.94B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new MEDP positions and 27 closed out — a net gain of 20 holders — while 118 added to existing stakes and 147 trimmed.
The largest buyer was Fuller & Thaler Asset Management, adding an estimated $53.2M. The largest seller was BlackRock, cutting an estimated $61.9M.
- 357 institutional investors held Medpace (MEDP) as of Q3 2022, up from 340 in Q2 2022.
- Funds reported $4.07B of Medpace stock for Q3 2022, up 3.3% quarter-over-quarter.
- 47 funds opened new Medpace positions in Q3 2022 and 27 closed out, a net change of +20 holders.
- The largest Medpace buyer in Q3 2022 was Fuller & Thaler Asset Management, an estimated $53.2M added.
- The largest Medpace seller in Q3 2022 was BlackRock, an estimated $61.9M sold.
Based on aggregated 13F filings for Q3 2022.